Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen
Keizo Kanasaki(Kanazawa Medical University), Daisuke Koya(Kanazawa Medical University), Yasuhito Ishigaki(Kanazawa Medical University), Munehiro Kitada(Kanazawa Medical University), Jianhua He(Kanazawa Medical University), Sen Shi(Kanazawa Medical University), Yuka Nakamura(The University of Osaka), Takako Nagai(Tokyo Women's Medical University Hospital), Megumi Kanasaki(Kanazawa Medical University), Swayam Prakash Srivastava(University of Michigan)
Cited by 369
Related Papers
Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
|Journal of Clinical Investigation|1997|537
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
|The FASEB Journal|2000|427
Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy
|Proceedings of the National Academy of Sciences|1997|381
Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus
|Journal of Molecular Medicine|1997|276